8-K - Gain Therapeutics, Inc. (0001819411) (Filer)
Published . Updated .
8-K - Gain Therapeutics filed an 8-K with the SEC on Oct 28 (a notice of a material company event).
Directly affected
- GANX Gain Therapeutics-31.2% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Gain Therapeutics belongs to, so it often moves with news about it.
- LLY Eli Lilly and+19.1% 30d
Eli Lilly and is a peer of Gain Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+1.9% 30d
Johnson & Johnson is a peer of Gain Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+10.2% 30d
AbbVie is a peer of Gain Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+1.0% 17d
Merck is a peer of Gain Therapeutics in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+1.4% 30d
Abbott Laboratories is a peer of Gain Therapeutics in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| GANX | +7.95% | -3.77% | base | -0.42% | -5.02% | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| LLYNo price data for this ticker | — | — | — | — | — | — | — |
| JNJNo price data for this ticker | — | — | — | — | — | — | — |
| ABBVNo price data for this ticker | — | — | — | — | — | — | — |
| MRKNo price data for this ticker | — | — | — | — | — | — | — |
| ABTNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-28 AccNo: 0001104659-26-119673 Size: 400 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial St…
Source: sec-edgar
How far Gain Therapeutics (GANX) has moved since 28 Oct 2026
| Company | When | Move | Status |
|---|---|---|---|
| Gain Therapeutics (GANX) | that day | -0.42% | final price |
| Gain Therapeutics (GANX) | the next day | -5.02% | final price |
| Gain Therapeutics (GANX) | three days earlier | -3.77% | final price |
| Gain Therapeutics (GANX) | five days earlier | +7.95% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 33 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 50 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 44 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought AbbVie (ABBV), worth $50,001 - $100,000 on 31 Jul 2026. That is 89 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 34 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 70 days before publication. Filed 9 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, sold Merck (MRK), worth $250,001 - $500,000 on 31 Jul 2026. That is 89 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 26 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 40 days before publication. Filed 12 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Gain Therapeutics, Inc. (0001819411) (Filer)”
Companies carried with this story
- GANX Gain Therapeutics
In “8-K - Gain Therapeutics, Inc. (0001819411) (Filer),” Gain Therapeutics (GANX) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> GANX
How “8-K - Gain Therapeutics, Inc. (0001819411) (Filer)” reaches Gain Therapeutics (GANX)
Gain Therapeutics (GANX) is the company in “8-K - Gain Therapeutics, Inc. (0001819411) (Filer),” the 28 Oct 2026 this story story.
For Gain Therapeutics (GANX), the reason on file says SEC 8-K filing -> direct issuer disclosure -> GANX
Price levels for Gain Therapeutics (GANX)
GANX traded between 1.16 and 1.96 across 20 sessions. The latest close on file is 1.20.
How solid “8-K - Gain Therapeutics, Inc. (0001819411) (Filer)” looks
14 out of 100
“8-K - Gain Therapeutics, Inc. (0001819411) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.